Sofocruz LP  Tablet - Ledipasvir (90mg) + Sofosbuvir (400mg) medicine

Hepcvir L 90mg/400mg Tablet: Complete Guide to Hepatitis C Treatment

No reviews yet
🏭 Torrent Pharmaceuticals Ltd 📦 strip of 28 tablets 💊 Allopathy 📅 Updated: Sep 25, 2026
⚠️ Hepatotoxicity Risk 🤰 Pregnancy Category There is no FDA pregnancy category for this medicine. Based on available data, it is not recommended during pregnancy unless the potential benefit justifies the potential risk. Animal studies have not shown clear harm, but human data are limited. Pregnancy should be planned in consultation with a liver specialist. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Sep 25, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Yellowing of the skin or eyes (jaundice)
  • Dark urine or pale stools
  • Severe abdominal pain, especially in the upper right side
  • Very slow or irregular heartbeat, fainting, or severe dizziness
  • Difficulty breathing or swelling of the face, lips, or throat
  • Extreme fatigue or confusion
  • Blood in vomit or black, tarry stools

If experiencing severe symptoms, call emergency services immediately.

What is Sofocruz LP Tablet used for?

This medicine is a combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, used to treat chronic hepatitis C virus (HCV) infection. It works by blocking two viral proteins needed for the virus to multiply. It is taken once daily, usually for 12 weeks, and can cure over 95% of cases in most patients.

  • Generic Name: Ledipasvir (90mg) + Sofosbuvir (400mg)
  • Manufacturer: Torrent Pharmaceuticals Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 Sofocruz LP Tablet के बारे में (Hindi Summary)

उपयोग: यह दवा लेडिपासवीर 90 मिलीग्राम और सोफोसबुवीर 400 मिलीग्राम का संयोजन है, जिसका उपयोग पुरानी हेपेटाइटिस सी (HCV) संक्रमण के इलाज के लिए किया जाता है। यह वायरस को शरीर में फैलने से रोकती है और अधिकांश रोगियों में 12 सप्ताह के भीतर वायरस को पूरी तरह खत्म कर सकती है। यह दवा आमतौर पर उन वयस्कों के लिए दी जाती है जिनमें HCV जीनोटाइप 1, 4, 5 या 6 पाया जाता है। इसे रोजाना एक बार खाने के साथ या बिना खाने के लिया जा सकता है। इलाज की अवधि और खुराक डॉक्टर द्वारा तय की जाती है।

साइड इफेक्ट्स: इस दवा के आम दुष्प्रभावों में सिरदर्द, थकान, जी मिचलाना, दस्त और नींद न आना शामिल हैं। ये आमतौर पर हल्के होते हैं और कुछ समय में ठीक हो जाते हैं। गंभीर दुष्प्रभाव दुर्लभ हैं, लेकिन यदि आपको पीलिया, गहरे रंग का पेशाब, तेज पेट दर्द, या दिल की धड़कन बहुत धीमी लगे तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: इस दवा को डॉक्टर के बताए अनुसार ही लें। खुराक न छोड़ें और इलाज बीच में न रोकें, भले ही आप बेहतर महसूस करें। इलाज के दौरान शराब बिल्कुल न पिएं। अपने डॉक्टर को अन्य सभी दवाओं, सप्लीमेंट्स और हर्बल उत्पादों के बारे में बताएं। नियमित रूप से लिवर फंक्शन और HCV RNA टेस्ट करवाएं। गर्भवती होने या गर्भधारण की योजना बनाने से पहले डॉक्टर से सलाह लें।

💡 Did You Know? India has the highest number of USFDA-compliant plants outside the USA.

💊 Sofocruz LP Tablet Uses & Benefits

[{"condition":"Chronic hepatitis C virus (HCV) genotype 1 infection","description":"This medicine is highly effective at achieving sustained virologic response (cure) in adults with chronic HCV genotype 1, with or without cirrhosis.","evidence":"Well-established"},{"condition":"Chronic hepatitis C virus (HCV) genotype 4 infection","description":"Used as a first-line treatment for chronic HCV genotype 4 infection in adults, often with or without ribavirin depending on prior treatment history and cirrhosis status.","evidence":"Well-established"},{"condition":"Chronic hepatitis C virus (HCV) genotype 5 or 6 infection","description":"Effective for treating chronic HCV genotypes 5 and 6 in adults, though data are more limited than for genotypes 1 and 4.","evidence":"Established"},{"condition":"HCV infection in patients with compensated cirrhosis","description":"Can be used in patients with compensated cirrhosis (Child-Pugh A) with excellent cure rates, sometimes with the addition of ribavirin.","evidence":"Well-established"},{"condition":"HCV infection in patients with HIV-1 coinfection","description":"Safe and effective in patients coinfected with HIV-1, provided their antiretroviral regimen does not contain contraindicated drugs.","evidence":"Established"}]

Off-label uses: [{"condition":"HCV genotype 2 or 3 infection","description":"Sometimes used off-label in combination with other direct-acting antivirals for genotypes 2 or 3, but not as monotherapy.","evidence":"Limited"},{"condition":"Prevention of HCV recurrence after liver transplant","description":"May be used off-label to prevent reinfection of the new liver in patients who had HCV before transplant.","evidence":"Emerging"}]

Primary treatment for: Chronic hepatitis C virus (HCV) infection

Also treats: Compensated cirrhosis due to HCV, HIV-1 coinfection with HCV, HCV recurrence after liver transplant

📋 Drug Information

Generic Name(s)Ledipasvir (90mg) + Sofosbuvir (400mg)
Brand NameSofocruz LP Tablet
ManufacturerTorrent Pharmaceuticals Ltd
Packaging / Formstrip of 28 tablets (Allopathy)
Therapeutic Class
Action Class
Route of AdministrationOral
StorageStore at room temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in their original container, tightly closed, away from moisture and heat. Do not refrigerate or freeze. Keep out of reach of children.
Shelf Life24 months from the date of manufacture, or as printed on the packaging. Do not use after the expiry date.
WHO GuidelineThe World Health Organization (WHO) recommends direct-acting antiviral regimens, including ledipasvir/sofosbuvir, for the treatment of chronic hepatitis C in adults and adolescents aged 12 years and older. WHO guidelines emphasize pan-genotypic regimens, but ledipasvir/sofosbuvir remains an option for specific genotypes.
ICMR GuidelineThe Indian Council of Medical Research (ICMR) guidelines for hepatitis C management include ledipasvir/sofosbuvir as a recommended regimen for genotypes 1, 4, 5, and 6, with or without ribavirin, depending on cirrhosis status and prior treatment history.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Take this medicine at the same time every day to maintain steady levels in your body.
2
Complete the full course of treatment even if you feel completely well, as stopping early can lead to treatment failure.
3
Avoid alcohol completely during treatment to protect your liver and improve cure rates.
4
Inform your doctor about all other medicines, especially amiodarone, rifampin, and St. John's wort, as they can interact dangerously.
5
Keep all scheduled blood tests, including HCV RNA and liver function tests, to monitor your response.
6
Use effective contraception during treatment and for at least one month after finishing, as the medicine may harm a developing baby.
7
If you experience dizziness, fainting, or a very slow heartbeat, seek medical help immediately.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Chronic fatigue and jaundice
This medicine is used for chronic hepatitis C, which can cause these symptoms.
Likely Use
❌
Fever
This medicine is not a fever reducer; fever may indicate another infection.
Not Primary
❌
Joint pain
This medicine is not primarily used for joint pain, though hepatitis C can cause joint aches.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionBoth ledipasvir and sofosbuvir are rapidly absorbed after oral administration. The absolute bioavailability of sofosbuvir is approximately 80%, while ledipasvir has a bioavailability of about 76% in healthy adults. Food does not significantly affect the absorption of either component, so the tablet can be taken with or without meals.
DistributionLedipasvir is highly bound to plasma proteins (approximately 99.8%), while sofosbuvir and its active metabolite are moderately bound (about 61–65%). Both drugs distribute well into the liver, the primary site of HCV infection. The volume of distribution is not well characterized in humans but is considered moderate.
Protein BindingLedipasvir: approximately 99.8% bound to plasma proteins. Sofosbuvir: approximately 61–65% bound to plasma proteins; its active metabolite GS-331007 is about 61% bound.
MetabolismSofosbuvir is extensively metabolized in the liver to its active triphosphate form via hydrolysis and phosphorylation; it is not a substrate of CYP enzymes. Ledipasvir is metabolized slowly, mainly by unknown mechanisms, with no significant involvement of CYP enzymes. Neither drug is a strong inhibitor or inducer of CYP enzymes.
Half-LifeThe effective half-life of ledipasvir is approximately 47 hours, while sofosbuvir and its active metabolite have half-lives of about 0.4 hours and 27 hours, respectively. These long half-lives support once-daily dosing.
ExcretionAfter oral administration, about 87% of sofosbuvir is excreted in urine (mostly as the inactive metabolite GS-331007) and 2% in feces. Ledipasvir is primarily excreted in feces (about 86%) and minimally in urine (about 1%).
BioavailabilitySofosbuvir: approximately 80%. Ledipasvir: approximately 76%.
Onset of ActionA rapid decline in HCV RNA levels can be observed within days of starting treatment, but the full therapeutic effect (sustained virologic response) is assessed 12 weeks after completing therapy.
Peak Plasma TimeLedipasvir: 4 to 4.5 hours after dosing. Sofosbuvir: 0.8 to 1 hour; its active metabolite peaks at 2 to 4 hours.
Duration of ActionThe antiviral effect persists as long as the drug is taken. The goal is a sustained virologic response, defined as undetectable HCV RNA 12 weeks after finishing treatment, which is considered a cure.

How It Works

This medicine combines two direct-acting antivirals that target different steps of the hepatitis C virus life cycle. Ledipasvir inhibits the NS5A protein, which is essential for viral RNA replication and the assembly of new virus particles. Sofosbuvir is a nucleotide analog that inhibits the NS5B RNA-dependent RNA polymerase, causing chain termination and blocking viral replication. Together, they produce a potent suppression of HCV replication, leading to viral clearance and sustained virologic response.

Mechanism Steps

1
Ledipasvir binds NS5A: Ledipasvir binds to the NS5A protein of HCV, disrupting its role in viral RNA replication and virion assembly.
2
Sofosbuvir inhibits NS5B: Sofosbuvir is converted inside cells to its active triphosphate form, which competes with natural nucleotides and incorporates into viral RNA, causing chain termination.
3
Dual blockade of replication: By hitting two distinct viral targets, the combination prevents the virus from replicating efficiently and reduces the chance of resistance.
4
Viral clearance: Continued treatment leads to a steep decline in HCV RNA, allowing the immune system to clear infected cells and achieve a sustained virologic response.

💡 How to Take Sofocruz LP Tablet

Strength: Film-coated tablet containing Ledipasvir 90 mg and Sofosbuvir 400 mg.

1Take one tablet at the same time each day, with or without food.
2Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet.
3If you take acid-reducing medicines, take them at the same time as this medicine with food, or separate doses as advised by your doctor.
4Do not skip doses. If you miss a dose, follow the missed dose instructions.
5Complete the full course of treatment even if you feel better.
6Store the tablets properly and keep them out of reach of children.

Dosage Information

Adult DosageThe usual adult dose is one tablet (Ledipasvir 90 mg + Sofosbuvir 400 mg) taken orally once daily, with or without food. The duration of treatment depends on the HCV genotype, presence of cirrhosis, and prior treatment history. For genotype 1, treatment is typically 12 weeks; for genotype 4, 12 weeks; for genotypes 5 or 6, 12 weeks. In patients with decompensated cirrhosis or prior treatment failure, the duration may be extended to 24 weeks and ribavirin may be added. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician or pediatric hepatologist for appropriate dosing in children under 18 years of age.
Elderly DosageNo dose adjustment is required based on age alone. However, elderly patients may have reduced renal or hepatic function and should be monitored accordingly. Dose must be individualized by a qualified clinician.
Renal ImpairmentNo dose adjustment is needed for mild or moderate renal impairment (eGFR ≥30 mL/min). For severe renal impairment (eGFR <30 mL/min) or end-stage renal disease requiring dialysis, the safety and efficacy of sofosbuvir have not been established. Use with caution and monitor renal function closely. Dose must be individualized by a qualified clinician.
Hepatic ImpairmentNo dose adjustment is needed for mild, moderate, or severe hepatic impairment (Child-Pugh A, B, or C). However, patients with decompensated cirrhosis (Child-Pugh B or C) should be monitored closely for signs of liver decompensation. Dose must be individualized by a qualified clinician.
Maximum Daily DoseOne tablet (Ledipasvir 90 mg + Sofosbuvir 400 mg) once daily. Do not exceed the recommended dose.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With or without food
Can be taken with or without food
Food does not affect absorption.
Grapefruit juice
Avoid large amounts
May affect drug metabolism, though specific interaction is not well established.
High-fat meals
No restriction
High-fat meals do not change drug levels.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours have passed since the missed dose
→ Take the missed dose as soon as you remember.
💡 Continue with your regular schedule.
📌 More than 12 hours have passed since the missed dose
→ Skip the missed dose.
💡 Do not double dose to catch up. Take the next dose at the regular time.

⚠️ Side Effects of Sofocruz LP Tablet

✅ Common Side Effects

Headache (Common (10-20%))
Usually resolves on its own. Rest, hydration, and over-the-counter pain relief may help. Consult your doctor if it persists.
Fatigue (Common (10-20%))
Get adequate rest and pace your activities. Report to your doctor if it interferes with daily life.
Nausea (Common (5-10%))
Take the tablet with a light meal. Avoid heavy, greasy foods. Contact your doctor if nausea is severe or persistent.
Diarrhea (Common (5-10%))
Stay hydrated and eat bland foods. Seek medical advice if diarrhea is severe or contains blood.
Insomnia (Common (5-10%))
Practice good sleep hygiene. Avoid caffeine in the evening. Talk to your doctor if sleep problems continue.

🚨 Serious Side Effects

Severe liver injury (Rare (<1%))
Seek immediate medical attention if you notice yellowing of the skin or eyes, dark urine, severe abdominal pain, or unusual fatigue.
Symptomatic bradycardia (slow heart rate) (Rare (<1%))
This can occur when taken with amiodarone or other heart-rate-lowering drugs. Seek emergency care if you experience fainting, dizziness, or a very slow pulse.
Severe allergic reaction (anaphylaxis) (Very rare (<0.1%))
Call emergency services immediately if you develop rash, swelling of the face or throat, or difficulty breathing.

⚠️ Rare Side Effects

Lactic acidosis
Report muscle pain, rapid breathing, or extreme tiredness to your doctor immediately.
Pancreatitis
Seek medical care if you have severe upper abdominal pain that radiates to your back.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Amiodarone Major
Rifampin Major
St. John's wort Major
Carbamazepine Major
Phenytoin Major
Omeprazole Moderate
Famotidine Moderate
Antacids Moderate
Rosuvastatin Moderate
Tenofovir Moderate

🚨 Major Interactions

  • Amiodarone
  • Rifampin
  • St. John's wort
  • Carbamazepine, phenytoin, phenobarbital
  • Proton pump inhibitors (e.g., omeprazole)

⚡ Moderate Interactions

  • H2 receptor antagonists (e.g., famotidine)
  • Antacids (aluminum/magnesium hydroxide)
  • Rosuvastatin
  • Tenofovir disoproxil fumarate

🍷 Alcohol Interaction

Alcohol should be avoided completely while taking this medicine. Alcohol can worsen liver inflammation and increase the risk of liver damage, especially in patients with hepatitis C. It may also reduce the effectiveness of treatment and increase the chance of side effects.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity to ledipasvir, sofosbuvir, or any component of the tablet","Use with amiodarone is contraindicated due to risk of serious bradycardia","Use with strong P-glycoprotein inducers such as rifampin, carbamazepine, phenytoin, phenobarbital, or St. John's wort","Pregnancy is not an absolute contraindication but treatment should be avoided unless clearly needed","Severe hepatic impairment (Child-Pugh C) is not recommended without specialist supervision"]

⚠️ Warnings & Precautions

["Serious symptomatic bradycardia has been reported when this medicine is taken with amiodarone. Avoid this combination unless no alternative exists, and monitor heart rate closely.","Do not use with other sofosbuvir-containing products to avoid overdose and toxicity.","Patients with advanced liver disease may be at risk of liver decompensation. Monitor closely.","Reactivating hepatitis B virus (HBV) has been reported in patients coinfected with HBV and HCV during treatment with direct-acting antivirals. Test for HBV before starting and monitor during treatment.","Use effective contraception during treatment and for at least 1 month after completion if you or your partner can become pregnant.","Do not share this medicine with others, even if they have similar symptoms.","Keep all follow-up appointments to monitor viral response and side effects."]

🤱 Lactation Safety

It is not known whether ledipasvir or sofosbuvir pass into breast milk. Because of the potential for adverse effects in a nursing infant, breastfeeding is not recommended during treatment. Discuss with your doctor about alternative feeding options.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. In case of suspected overdose, stop the medicine and seek immediate medical attention. Treatment should be supportive and symptomatic. Monitor vital signs, liver function, and heart rate. Hemodialysis is not expected to remove ledipasvir or sofosbuvir significantly because they are highly protein-bound.

⏰ Missed Dose

If you miss a dose and remember within 12 hours of the scheduled time, take it as soon as you remember. If more than 12 hours have passed, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose.

Additional Safety Advice

General Safety

Take this medicine exactly as prescribed, usually once daily with or without food. Do not skip doses or stop early, even if you feel better. Keep all laboratory appointments, especially liver function tests and HCV RNA viral load checks. Tell your doctor about all other medicines, supplements, and herbal products you take, because this medicine can interact with many drugs, including acid reducers, anti-seizure medicines, and some heart medicines. Avoid alcohol completely during treatment to protect your liver. Use effective contraception during treatment if you or your partner could become pregnant. Store the tablets at room temperature away from moisture and heat. Do not use if the seal is broken or the expiry date has passed.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients (above 65 years) can take this medicine, but they may have reduced kidney or liver function and other medical conditions. Monitor renal and hepatic function closely. No dose adjustment is required based on age alone, but individualized assessment is important.

🤰 Pregnancy Planning (TTC)

If you are planning to become pregnant, discuss with your doctor before starting this medicine. It is not recommended during pregnancy unless clearly needed. Use effective contraception during treatment and for at least one month after completion. If you become pregnant while taking this medicine, contact your doctor immediately.

🏥 Post-Surgery Considerations

If you have surgery planned, inform your surgeon and anesthesiologist that you are taking this medicine. It may interact with certain medications used during surgery. Do not stop the medicine without your doctor's advice. Continue treatment as prescribed unless told otherwise.

🦷 Dental Procedures

Inform your dentist that you are taking this medicine before any dental procedure. There are no specific restrictions, but maintaining good oral hygiene is important. If you need dental work, it is generally safe to continue the medicine.

💚 Lifestyle Tips for Better Results

🏃
Avoid alcohol completely to protect your liver.
🥗
Eat a balanced diet rich in fruits, vegetables, and whole grains.
😴
Stay physically active with moderate exercise as tolerated.
💧
Get plenty of rest and manage stress.
🧘
Do not share needles, razors, or toothbrushes to prevent reinfection.
🌞
Practice safe sex to prevent transmission of hepatitis C.
🚭
Keep all follow-up appointments with your doctor.

🏋️ Exercise Considerations

Moderate exercise is generally safe and beneficial while taking this medicine. However, if you have advanced liver disease or feel very fatigued, consult your doctor before starting a new exercise routine. Avoid strenuous activities if you experience dizziness or a slow heartbeat.

🥗 Diet Recommendations

Eat a well-balanced diet with plenty of fruits and vegetables.
Choose lean proteins such as fish, chicken, and beans.
Limit processed foods, sugary drinks, and saturated fats.
Stay well hydrated by drinking plenty of water.
Avoid alcohol and recreational drugs.

💼 Impact on Daily Work & Life

Most people can continue their normal daily activities, including work and driving, while taking this medicine. However, if you experience fatigue, dizziness, or a slow heartbeat, avoid driving or operating heavy machinery until you feel better. Inform your employer if you need flexible hours for medical appointments.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your doctor. Treatment is usually for a fixed duration (12 or 24 weeks). If you experience severe side effects such as jaundice, severe abdominal pain, or a very slow heartbeat, seek immediate medical attention and your doctor will decide whether to stop the medicine.

📅 Long-Term Use Effects

Long-term effects of this medicine are generally positive, as it can cure hepatitis C and prevent progression to cirrhosis and liver cancer. However, patients with existing cirrhosis remain at risk of liver complications and should continue regular monitoring even after cure. There are no known long-term toxicities from the medicine itself, but ongoing liver health surveillance is recommended.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Sofosbuvir + Velpatasvir

A pan-genotypic direct-acting antiviral combination that can be used as an alternative, especially for genotypes not covered by this medicine.

Evidence: Well-established
Glecaprevir + Pibrentasvir

Another pan-genotypic option, useful for patients with renal impairment or those who cannot take sofosbuvir.

Evidence: Well-established
Lifestyle modifications

Avoiding alcohol, maintaining a healthy weight, and regular exercise support liver health but do not replace antiviral treatment.

Evidence: Supportive

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

There is no vaccine for hepatitis C. However, patients with hepatitis C should be vaccinated against hepatitis A and hepatitis B to prevent additional liver damage. Discuss with your doctor about appropriate vaccinations before or during treatment.

📦 Storage Guide

✅ DO

Store at room temperature (15-30°C)

❌ DON'T

Do not refrigerate or freeze

✅ DO

Keep in the original container tightly closed

❌ DON'T

Do not transfer to unmarked containers

✅ DO

Keep away from direct sunlight and moisture

❌ DON'T

Do not store in the bathroom

✅ DO

Keep out of reach of children

❌ DON'T

Do not use after the expiry date

✈️ Traveling with This Medicine

When traveling, carry your medicine in its original packaging with a copy of your prescription. Keep it in your hand luggage to avoid loss or temperature extremes. Store at room temperature and avoid leaving it in a hot car. If crossing time zones, continue taking your dose at the same time each day according to your home schedule, or adjust gradually as advised by your doctor. Check customs regulations for carrying prescription medicines into your destination country.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 52-year-old man with chronic hepatitis C genotype 1 and compensated cirrhosis
He was started on this medicine for 12 weeks. He took it daily with breakfast and avoided alcohol completely. His HCV RNA became undetectable by week 4 and remained undetectable 12 weeks after treatment. He reported mild fatigue during the first month but otherwise tolerated it well.
💡 Lesson: Adherence to daily dosing and regular monitoring led to a successful cure even with cirrhosis.
👤 A 38-year-old woman with hepatitis C genotype 4 and no cirrhosis
She completed 12 weeks of this medicine. She experienced mild headaches and nausea, which were managed by taking the tablet with food and staying hydrated. She was cured and her liver enzymes normalized. She was advised to use contraception during treatment and for one month after.
💡 Lesson: Common side effects are manageable with simple measures, and completing the full course is essential for a cure.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts reducing the virus within days, but the full cure is assessed 12 weeks after completing treatment. Most patients achieve undetectable virus by the end of treatment.

Q: Can I stop taking this medicine if I feel better?

A: No, you must complete the full course as prescribed. Stopping early can allow the virus to return and may lead to resistance.

Q: What should I do if I miss a dose?

A: If you remember within 12 hours, take it as soon as possible. If more than 12 hours have passed, skip the missed dose and continue with your regular schedule. Do not double dose.

Q: Can I drink alcohol while on this medicine?

A: No, alcohol should be avoided completely as it can worsen liver damage and reduce the effectiveness of treatment.

Q: Is this medicine safe during pregnancy?

A: It is not recommended during pregnancy unless clearly needed. Discuss with your doctor and use effective contraception during treatment.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Is it safe to take with my HIV medicines?
  • Will I need to take ribavirin too?

🛑 Myths vs. Facts

  • Myth: This medicine can prevent hepatitis C.
    Fact: This medicine treats existing hepatitis C infection but does not prevent it. Prevention requires avoiding contact with infected blood and practicing safe behaviors.
  • Myth: You can stop taking this medicine once you feel better.
    Fact: You must complete the full course as prescribed, even if you feel better, to ensure the virus is completely cleared and to prevent resistance.
  • Myth: This medicine is safe to take with any other medicine.
    Fact: This medicine can interact with many drugs, including amiodarone, rifampin, and St. John's wort. Always check with your doctor before taking any other medicine.
  • Myth: Hepatitis C is always cured with a single course of this medicine.
    Fact: While cure rates are very high, some patients may need a longer duration or additional medicines, especially if they have cirrhosis or prior treatment failure.

🔄 Alternative Options

Generic Alternatives

  • Ledipasvir + Sofosbuvir (generic)

Brand Alternatives

  • Hepcvir L
  • Ledifos
  • Hepcinat LP

📊 Comparison with Similar Medicines

[{"medicine":"Ledipasvir + Sofosbuvir (this medicine)","genotype_coverage":"1, 4, 5, 6","duration":"12-24 weeks","cure_rate":">95%","key_feature":"Well-established for genotypes 1 and 4"},{"medicine":"Sofosbuvir + Velpatasvir","genotype_coverage":"1-6 (pan-genotypic)","duration":"12 weeks","cure_rate":">95%","key_feature":"Broad genotype coverage"},{"medicine":"Glecaprevir + Pibrentasvir","genotype_coverage":"1-6 (pan-genotypic)","duration":"8-16 weeks","cure_rate":">95%","key_feature":"Shorter duration for some patients; option for renal impairment"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory